1. Home
  2. RGP vs TLSA Comparison

RGP vs TLSA Comparison

Compare RGP & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Resources Connection Inc.

RGP

Resources Connection Inc.

N/A

Current Price

$2.80

Market Cap

130.4M

ML Signal

N/A

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

N/A

Current Price

$1.18

Market Cap

145.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RGP
TLSA
Founded
1996
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
130.4M
145.1M
IPO Year
2000
2017

Fundamental Metrics

Financial Performance
Metric
RGP
TLSA
Price
$2.80
$1.18
Analyst Decision
Buy
Strong Buy
Analyst Count
4
2
Target Price
$5.67
★ $8.02
AVG Volume (30 Days)
406.2K
★ 582.2K
Earning Date
10-07-2026
05-01-2026
Dividend Yield
★ 9.37%
N/A
EPS Growth
★ 79.14
N/A
EPS
N/A
★ N/A
Revenue
★ $452,006,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.01
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.88
$0.76
52 Week High
$5.37
$2.20

Technical Indicators

Market Signals
Indicator
RGP
TLSA
Relative Strength Index (RSI) 19.83 60.42
Support Level N/A $1.14
Resistance Level $4.63 $1.20
Average True Range (ATR) 0.18 0.09
MACD -0.09 0.02
Stochastic Oscillator 0.41 76.81

Price Performance

Historical Comparison
RGP
TLSA

About RGP Resources Connection Inc.

Resources Connection Inc is a professional services firm. Its segments include On-Demand Talent provides businesses with a go-to source for bringing in experts when its needed, serving the office of the CFO; Consulting drives transformation across people, processes and technology across domain areas including finance, technology and digital, risk and compliance and operational performance; Europe & Asia Pacific offers both on-demand and consulting services to clients throughout Europe and Asia Pacific; Outsourced Services; and Sitrick. It derives the majority of revenue from On-Demand Talent segment. Geographically, it operates in United States and internationally.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: